Therapeutic potential of triphala against human diseases

International Journal of Pharmaceutical Sciences Review and Research

Volumn 31, Issue 2, 2015, Pages 5-13

  Bhatnagar, Sonal ^a   Rani, Anita ^b   Kumari, Reeta ^c  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Anticancerous; Chebulic acid; Emblica officinalis; Gallic acid; Terminalia bellerica; Terminalia chebula

Indexed keywords

ANTILIPEMIC AGENT; ASCORBIC ACID; AYURVEDIC DRUG; CARBOHYDRATE; CHEBULAGIC ACID; CHEBULANIN ACID; CHEBULIC ACID; CHEBULINIC ACID; CORILAGIN; DISINFECTANT AGENT; ELLAGIC ACID; EMBLICA OFFICINALIS EXTRACT; GALLIC ACID METHYL ESTER; LAXATIVE; PLANT EXTRACT; RADIOPROTECTIVE AGENT; SAPONIN; SORBITOL; TANNIN DERIVATIVE; TERMINALIA BELLERICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRIPHALA; UNCLASSIFIED DRUG;

AGING; ANALGESIC ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; DIGESTION; DISEASES; HUMAN; IMMUNOMODULATION; METABOLISM; MUTAGENESIS; NUTRIENT UPTAKE; ULCEROGENESIS;

EID: 84928201211     PISSN: 0976044X     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Jagetia GC, Baliga MS, Malagi KJ, Kamath SM, The evaluation of the radioprotective effect of Triphala (an Ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation, Phytomedicine, 9, 2002, 99-108.
2. Jagetia GC, Malagi KJ, Baliga MS, Venkatesh P, Veruva RR, Triphala, an ayurvedic rasayana drug, protects mice against radiationinduced lethality by free-radical scavenging, Journal of Alternative and Complementary Medicine, 10, 2004, 971-978.
3. Biradar YS, Jagatap SH, Khandelwal KR, Singhania SS, Exploring of antimicrobial activity of Triphala Mashi-an ayurvedic formulation, Evidence-Based Complementary and Alternative Medicine, 5, 2008, 107-113.
4. Kumar MS, Kirubanandan S, Sripriya R, Sehgal PK, Triphala promotes healing of infected full-thickness dermal wound, Journal of Surgical Research, 144(1), 2008, 94-101.
5. Sharma RK, Dash B, Carka Samhita Volume II,. Chowkamba Sanskrit Series Office, Varanasi, India, 1998.
6. Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, Hari Mohan, In vitro antioxidant studies and free radical reactions of Triphala, an ayurvedic formulation and its constituents, Phytotherapy Research, 19, 2005, 582-586.
7. Suvarajan VV, Ayurvedic drugs and their plant sources, Lebanon, NH, International Science Publisher, 1994.
8. Suresh K, Vasudevan DM, Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immuno modulator, Journal of Ethnopharmacology, 44, 1994, 55-60.
9. Tokura K, Kagawa S, Anti cancer agents containing chebulanin from Terminalia chebula, Japan Kokai Tokyo Koho, JP, 7, 1995, 138-65.
10. Ghosal S, Tripathi VK, Chauhan S, Active constituents of Emblica officinalis, Part I, The chemistry and antioxidative effects of two new hydrolysable tannins, emblicanin A and B, Indian Journal of Chemistry, 35, 1995, 941-948.
11. Bhattacharya A, Antioxidant activity of active tannoid principles of Emblica officinalis (amla), Indian Journal of Experimental Biology, 37, 1999, 676-680.
12. Kaur S, Arora S, Kaur K, Kumar S, The in vitro antimutagenic activity of Triphala-an Indian herbal drug, Food and Chemical Toxicology, 40(4), 2002, 527-534.
13. Sabu MC, Kuttan R, Anti-diabetic activity of medicinal plants and it's relationship with their antioxidant property, Journal of Ethno pharmacology, 81(2), 2002, 155-162.
14. Sharma A, Kumar K,. Chemo protective role of Triphala against 1, 2-dimethylhydrazine dihydrochloride induced carcinogenic damage to mouse liver, Indian Journal Clinical Biochemistry, 26(3), 2011, 290-295.
15. Ahmad I, Mehmood Z, Mohammad F, Screening of some Indian medicinal plants for their antimicrobial properties, Journal of Ethnopharmacology, 62, 1998, 183-193.
16. Jose JK, Kuttan R, Hepatoprotective activity of Emblica officinalis and chyavanaprash, Journal of Ethnopharmacology, 72, 2000, 135-140.
17. Naik GH, Priyadarsinia KI, Naika DB, Gangabhagirathi R, Mohana H, Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector, Phytomedicine, 11, 2004, 530-538.
18. Sandhya T, Lathika KM, Pandey BN, Mishra KP, Potential of ayurvedic formulation, Triphala, as novel anticancer drug, Cancer Letters, 231(02), 2006, 206-214.
19. Kaur S, Michael H, Arora S, Harkonen PL, Kumar S, The in vitro cytotoxic and apoptotic activity of Triphala-An Indian herbal drug, Journal of Ethnopharmacology, 97, 2005, 15-20.
20. Kirubanandan S, Swethkamal K, Renganathan S, Activities of Triphala towards promoting collagen synthesis at wound site and inhibiting methicillin resistant Staphylococcus aureus and its enzymes, International Journal of Pharmacy and Pharmaceutical Sciences, 5(2), 2013, 54-62.
21. Deep G, Dhiman M, Rao AR, Kale RK, Chemopreventive potential of Triphala (a composite Indian drug) in benzo (a) pyrene induced for estomachtumorgenesis in murine tumor model system, Journal of Experimental & Clinical Cancer Research, 24(4), 2005, 555-563.
22. Sushruta Sushruta Samhita DalhanaComm-Nibandhasangraha, Chowkhambha Orientalia Varanasi, Sutrasthana, 46(143), 2002, 227.
23. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C, Vitamin C content and antioxidant activity of the fruit and of the ayurvedic preparation of Emblica officinalis Gaertn., Journal of Ethnopharmacology, 104, 2006, 113-118.
24. Bhattacharya A, Ghosal S, Bhattacharya SK, Antioxidant activity of tannoid principles of Emblica officinalis (Amla) in chronic stress induced changes in rat brain, Indian Journal Experimental Biology, 38(9), 2000, 877-880.
25. Al-Rehaily AJ, Al-Howiriny TA, Al-Sohaibani MO, Rafatullah S, Gastroprotective effects of Amla, Emblica officinalis on in vivo test models in rats, Phytomedicine, 9(6), 2002, 515-522.
26. Agrawal RC, Rajani, Evaluation of anticarcinogenic and antimutagenic effects of Triphala extract, International Journal Science Research Publication, 2(6), 2012, 1-6.
27. Rani P, Khullar N, Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi, Phytotherepy Research, 18, 2004, 670-673.
28. Sultana S, Ahmed S, Sharma S, Jahangir T, Emblica officinalis reverses thioacetamide-induced oxidative stress and early promotional events of primary hepatocarcinogenesis, Journal of Pharmacy and Pharmacology, 56, 2004, 1573-1579.
29. Adams LS, Seeram NP, Aggarwal BB, Takada Y, S and D, Heber D, Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signalling in colon cancer cells, Journal of Agriculture and Food Chemistry, 54, 2006, 980-985.
30. Buzzini P, Arapitsas P, Goretti M, Branda E, Turchetti B, Pinelli P, Ieri F, Romani A, Antimicrobial and antiviral activity of hydrolysable tannins, Mini-Review in Medicine Chemistry, 8, 2008, 1179-1187.
31. Poltanov EA, Shikov AN, Dorman HJD, Pozharitskaya ON, Makarov VG, Tikhonov VP, Hiltunen R, Chemical and antioxidant evaluation of Indian gooseberry (Emblica officinalis Gaertn., syn. Phyllanthus emblica L.) supplements, Phytotherapy Research, 23, 2009, 1309-1315.
32. Ryu YB, Kim JH, Park SJ, Chang JS, Rho MC, Bae KH, Park KH, Lee WS, Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis, Bioorganic and Medicinal Chemistry Letters, 20(3), 2010, 971-974.
33. Sreeramulu D, Raghunath M, Antioxidant activity and phenolic content of roots, tubers and vegetables commonly consumed in India, Food Research International, 43, 2010, 1017-1020.
34. Luo W, Zhao MM, Yang B, Shen GL, Rao GH, Identification of bioactive compounds in Phyllanthus emblica L. fruit and their free radical scavenging activities, Food Chemistry, 114, 2009, 499-504.
35. Jose JK, Kuttan G, Kutan R. Anti-tumour activity of Emblica officinalis, Journal of Ethnopharmacology, 75, 2001, 65-69.
36. Ponnusankara S, Pandita S, Babub R, Bandyopadhya A, Mukherjee PK, Cytochrome P450 inhibitory potential of Triphala-A rasayana from ayurveda, Journal of Ethnopharmacology, 133, 2011, 120-125.
37. Padam SK, Grover IS, Singh M, Antimutagenic effects of polyphenols isolated from Terminalia bellerica myroblan in Salmonella typhimurium, Indian Journal of Experimental Biology, 34(2), 1996, 98-102.
38. Elizabeth KM, Antimicrobial activity of Terminalia bellerica, Indian Journal of Clinical Biochemistry, 20, 2005, 150-153.
39. Valsaraj R, Pushpangadan P, Smitt UW, Adsersen A, Christensen SB, Sittie A, Nyman U, Nielsen C, Olsen CE, New anti-HIV-1, antimalarial, and antifungal compounds from Terminalia bellerica, Journal of Natural Products, 60, 1997, 739-742.
40. Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C, Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells, World Journal of Gastroenterology, 14, 2008, 1491-1497.
41. Shukla S, Jadon A, Bhadauria M, Protective effect of Terminalia bellerica Roxb., and gallic acid against carbon tetra chloride induced damage in albino rats, Journal of Ethnopharmacology, 109, 2006, 214-218.
42. Latha RCR, Daisy P, Influence of Terminalia bellerica Roxb. fruit extracts on biochemical parameters in streptozotocin diabetic rats, International Journal of Pharmacology, 6, 2010, 89-96.
43. Gopinathan G, Dhiman KS, Triphala in eye diseases: A critical review, Journal of Homeopathy & Ayurvedic Medicine, 2, 2013, 123.
44. Anand KK, Singh B, Saxena AK, Chandan BK, Gupta VN, Bhardwaj V, 3, 4, 5-Trihydroxybenzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia bellerica bioassay guided activity, Pharmacological Research, 36, 1997, 315-321.
45. Mukherjee PK, Rai S, Kumar V, Mukherjee K, Hylands PJ, Hider RC, Plants of Indian origin in drug discovery, Expert Opinion on Drug Discovery, 2, 2007, 633-657.
46. Prasad L, Husain Khan T, Jahangir T, Sultana S, Chemomodulatory effects of Terminalia chebula against nickel chloride induced oxidative stress and tumor promotion response in male Wistar rats, Journal of Trace Element in Medicine Biology, 20, 2006, 233-239.
47. Bag A, Bhattacharyya SK, Pal KK, Chattopadhyay RR, In vitro antimicrobial potential of Terminalia chebula fruit extracts against multidrug-resistant uropathogens, Asian Pacific Journal of Tropical Biomedicine, 2(3), 2012, S1883-S1887.
48. Agnivesha Charaka Samhita, Comm-Chakrapanidatta, Bhagawandash, ChowkhambaSanskrita Series, Varanasi, Chikitsasthana, 1(34), 1984, 378.
49. Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J, In vitro anti-aging activities of Terminalia chebula gall extract, Pharmaceutical Biology, 48, 2010, 469-481.
50. Das ND, Jung KH, Park JH, Mondol MA, Shin HJ, Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cells, Phytotherapy Research, 25, 2011, 927-934.
51. Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Scientific validation of the ethnomedicinal properties of the ayurvedic drug Triphala: a review, Chinese Journal of Integrative Medicine, 18, 2012, 946-954.
52. Gautam MK, Goel S, Ghatule RR, Singh A, Nath G, Curative effect of Terminalia chebula extract on acetic acid-induced experimental colitis, role of antioxidants, free radicals and acute inflammatory marker, Inflammopharmacology, 21(5), 2012, 377-383.
53. Mishra V, Agrawal M, Onasanwo SA, Madhur G, Rastogi P, Pandey HP, Palit G, Narender T, Antisecretory and cyto-protective effects of chebulinic acid isolated from the fruits of Terminalia chebula on gastric ulcers, Phytomedicine, 20, 2013, 506-511.
54. Malckzadeh F, Ehsanifar H, Shahamat N, Levin M, Colwell RR, Antibacterial activity of black myrobalan (Terminalia chebula Retz.) against Helicobacter pyroli, International Journal of Antimicrobial Agents, 18(1), 2001, 85-88.
55. Saleem A, Husheem M, Härkönen, Pihlaja K, Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. Fruit, Journal of Ethno pharmacology, 81, 2002, 327-336.
56. Kaur S, Grover IS, Singh M, Kaur S, Antimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimurium, Mutation Research, 419, 1998, 169-179.
57. Shin TY, Jeong HJ, Kim DK, Kim SH, Lee JK, Kim DK, Chae BS, Kim JH, Kang HW, Lee CM, Lee KC, Park ST, Lee EJ, Lim JP, Kim HM, Lee YM, Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxis, Journal of Ethno pharmacology, 74(2), 2001, 133-140.
58. Sharma S, Chemical investigation of Terminalia bellerica, Acta Chimica Pharmaceutica Indica, 2(3), 2012, 132-133.
59. Jadon A, Bhadauria M, Shukla S, Protective effect of Terminalia bellerica Roxb. And gallic acid against carbon tetrachloride induced damage in albino rats, Journal of Ethno pharmacology, 109, 2007, 214-218.
60. Khan KH, Roles of Emblica officinalis in medicine-A review, Botany Research International, 2, 2009, 218-228.
61. Chatterjee A, Pakrashi SC, The treatise on Indian medicinal plants, 3, 2003, 34-35.
62. Bose S, Sinha SK, Mukherjee G, In-vitro study of Triphala on antioxidant activity, Science & Culture, 77(11-12), 2011, 511-513.
63. Lin TC, Nonaka G, Nishioka I, Ho FC, Tannins and related compounds. CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula Retz, Chemical and Pharmaceutical Bulletins, 38, 1990, 3004-3008.
64. Lin TC, Chien SC, Chen HF, Hsu FL, Tannins and related compounds from Combretaceae plants, Chinese Pharmaceutical Journal, 52, 2000, 1-26.
65. Varier, A dictionary of Indian raw materials and industrial products, New Delhi, Publications and Information Directorate, Council of Scientific and Industrial Research, 2002, 387.
66. Juang LJ, Sheu SJ, Lin TC, Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis, Journal of Separation Science, 27, 2004, 718-724.
67. Mahesh R, Ramesh T, Nagulendran KR, Velavan S, Hazeena BV, Effect of Terminalia chebula on monoamine oxidase and antioxidant enzyme activities in aged rat brain, Pharmacognosy Magazine, 3, 2007, 12-16.
68. Mahajan A, Pai N, Simultaneous isolation and identification of phytoconstituents from Terminalia chebula by preparative chromatography, Journal of Chemical and Pharmaceutical Research, 2(5), 2010, 97-103.
69. Prakash SDV, Satya NS, Avanigadda S, Vangalapati M, Pharmacological review on Terminalia chebula, International Journal of Research in Biomedical and Pharmaceutical Sciences, 3(2), 2012, 679-683.
70. Savitha T, Thangamariappan K, Terminalia chebula: Therapeutic boon to mankind, International Journal of Pharmacy and Integrated Life Sciences, 1(9), 2013, 1-15.
71. Inoue M, Suzuki, Isuzugawa K, Ogihara Y, Inoue M, Different generation of inhibitors against gallic acid-induced apoptosis produces different sensitivity to gallic acid, Biological and Pharmaceutical Bulletin, 24, 1995, 249-253.
72. Yoshioka K, Kataoka T, Hayashi T, Hasegawa M, Ishi Y, Hibasami H, Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines, Oncology Reports, 2000, 1221-1223.
73. ShiYan, Sahu RP, Srivastava SK, Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis, BMC Cancer, 8, 2008, 294.
74. Sharma A, Sharma KK, Chemoprotective role of Triphala against 1, 2-Dimethylhydrazine Dihydrochloride induced carcinogenic damage to mouse liver, Indian Journal of Clinical Biochemistry, 26(3), 2011, 290-295.
75. Ali SS, Kasoju N, Luthra A, Singh A, Sharanabasava H, Sahu A, Bora U, Indian medicinal herbs as sources of antioxidants, Food Research International, 41, 2008, 1-15.
76. Sindhi V, Gupta V, Sharma K, Bhatnagar S, Kumari R, Dhaka N,. Potential applications of antioxidants-A review, Journal of Pharmacy Research, 7(9), Journal of Pharmaceutical Research 2013, 2013, 828-835.
77. Naik GH, Priyadarsini KI, Mohan H, Free radical scavenging reactions and phytochemical analysis of Triphala, an ayurvedic formulation, Current Science, 90(8), 2006, 1100-1105.
78. Vani T, Rajani M, Sarkar S, Shishoo CJ, Antioxidant Properties of the ayurvedic formulation Triphala and its constituents, Pharmaceutical Biology, 35(5), 1997, 313-317.
79. Gupta M, Therapeutic uses of the polyherbal drug Triphala in geriatric diseases, International Journal of Pharma and Bio Sciences, V1(2), 2010, 1-13.
80. Saravanan S, Srikumar R, Manikandan S, Parthasarathy JN, Devi SR, Hypolipidemic effect of Triphala in experimentally induced hypercholesteremic rats, Yakugaku Zasshi, 2007; 127(2):, 2007, 385-388.
81. Rana S, A study on comparative hypolipidemic activity of different ratios of Triphala submitted for the partial fulfillment of M. Pharmacy, Department of Pharmacology and toxicology, St. John's Pharmacy College, Vijaynagar, Bangalore, 2011.
82. Muthusamy SK, Kirubanandan S, Sripriya, Sehgal PK, Triphala promotes healing of infected full thickness dermal wound, Journal of Surgical Research, 144, 2008, 94-101.
83. Kasahara, Hikino YH, Tsurufiji S, Watanabe M, Ohuchi K, Antiinflammatory actions of ephedrines in acute inflammations, Planta Medica, 51, 1985 325-331.
84. Sabina EP, Rasool M, Analgesic, antipyretic and ulcerogenic effects of Indian ayurvedic herbal formulation Triphala, Research Journal of Medicinal Plant, 1(2), 2007, 54-59.
85. Tamhane MD, Thorat SP, Rege NN, Dahanukar SA, Effect of oral administration of Terminalia chebulaon gastric emptying, an experimental study, Journal of Postgraduate Medicine, J Postgrad Med, 43, 1997, 12-13.
86. Abraham S, Kumar MS, Sehgal PK, Nitish S, Jayakumar ND, Evaluation of inhibitory effect of Triphala on PMN-type matrix metalloproteinase (MMP-9), Journal of Periodontology, 76, 2005, 497-502.
87. Tillotson A, Kalsa KPS, Caldecott T, Triphala, Canadian Journal of Herbalism, 22(2), 2001, 16-44.
88. Desai A, Anil M, Debnath S, A clinical trial to evaluate the effects of Triphala as a mouthwash in comparison with chlorhexidine in chronic generalised periodontitis patient, Indian Journal of Dental Research, 2(3), 2010, 243-247.
89. Bhatnagar S, Sahoo S, Behera DR, Mohapatra AK, A study on seasonal variation in cytotoxic and antioxidant activities of of Terminalia bellerica, International Journal of Biomedical and Advance Research, 2011, 2(11), 427-434.
90. Dutta BK, Rahman I, Das TK, Antifungal activity of Indian plant extracts, Mycoses, 41, 1998, 535-536.
91. Al-Daihan S, Al-Faham M, Al-shawi N, Almayman R, Brnawi A, Zargar S, Bhat RS, Antibacterial activity and phytochemical screening of some medicinal plants commonly used in Saudi Arabia against selected pathogenic microorganisms, Journal of King Saud University-Science, 2013, 25(2), 115-120.
92. Mukherjee PK, Rai S, Bhattacharyy S, Debnath PK, Biswas TK, Jana U, Pandit S, Saha BP, Paul PK, Clinical study of Triphala-A well knownphytomedicine from India, Iranian Journal of Pharmacology & Therapeutics, 5, 2006, 51-54.
93. Dixit D, Dixit AK, Lad H, Gupta D, Bhatnagar D, Radioprotective effect of Terminalia Chebula Retzius extract against γ-irradiationinduced oxidative stress, Biomedicine & Aging Pathology, 3(2), 2013, 83-88.
94. Rajan SS, Antony S, Hypoglycemic effect of Triphala on selected non insulin dependent diabetes mellitus subjects, Ancient Science of Life, XVII (3), 2008, 45-49.
95. Phetkate P, Kummalue T, U-pratya Y, Kietinun S, Significant increase in cytotoxic T lymphocytes and natural killer cells by Triphala: A clinical phase I study, Evidence-based Complementary and Alternative Medicine, 2012, 1-6.
96. El-Mekkawy M, Merelhy M, Inhibitory effects of folk medicines on human immunodeficiency virus (HIV) reverse transcriptase, Chemical and Pharmaceutical Bulletin, 43, 1995, 641-648.
97. Srikumar R, Parthasarathy NJ, Shankar EM, Manikandan S, Vijayakumar R, ThangaraR Vijayananth K, Sheeladevi R, Rao UA, Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients, Phytotherapy Research, 21, 2007, 476-80.
98. Safiullah A, Harish CC, Vijay AK, Saira K, Antimicrobial activity of Triphala against bacterial isolates from HIV infected patients, Jundishapur Journal of Microbiology, 4(1), 2011, S9-S17.
99. Rege NN, Thatte UM, Dahanukar SA, Adaptogenic properties of six rasayana herbs used in ayurvedic medicine, Phytotherapy Research, 13, 1999, 275-291.
100. Srikumar R, Parthasarathy NJ, Rathinasamy, Devi RS, Immunomodulatory activity of Triphala on neutrophil functions, Biological and Pharmaceutical Bulletin, 28(8), 2005, 1398-1403.
101. Singh R, Singh B, Kumar BN, Arora S. Antioxidant activity of Triphala a combination of Terminalia chebula, Terminalia bellerica and Emblica officinalis, Journal of Food Biochemistry, 34, 2010, 222-232.